Noninvasive fetal genotyping using deep neural networks
Briefings in Bioinformatics · 22.11.2024 · 26 (1)
DOI: 10.1093/bib/bbaf067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 24.02.2025. Verfasst von Yonathan Schwammenthal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel. Hauptthemen laut MEDLINE: Deep Learning, Cell-Free Nucleic Acids, Neural Networks, Computer, Prenatal Diagnosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Circulating cell-free DNA (cfDNA) is a powerful diagnostics tool that is widely studied in the context of liquid biopsy in oncology and other fields. In obstetrics, maternal plasma cfDNA have already proven its utility, enabling noninvasive prenatal testing (NIPT), which has become a standard for detecting chromosomal aberrations. However, identification of point mutations responsible for monogenic diseases (NIPT-M) remains limited, even when accounting to fragment specific characteristics (i.e. fragmentomics). While genotyping of individual genomes is performed today using deep learning (DL) algorithms, cfDNA-based noninvasive fetal genotyping is performed only using traditional statistical and machine-learning methods. This study introduces the first DL-based framework for cfDNA based genotyping, heralding a significant stride toward genome-wide NIPT-M. Using unique ultra-deep whole genome sequencing (WGS) data, we were motivated to develop an efficient model, especially when compared with current DL methods for WGS. This facilitates the integration of previously overlooked levels of information, encompassing DNA nucleotides, fragments, mutation regions, samples, and familial traits. Employing this novel approach, we surpass the performance of existing methodologies, successfully detecting three deleterious mutations, and allowing for NIPT-M as early as the 7th week of gestation. Our proposed approach brings genome-wide NIPT for all mutation types closer to clinical feasibility, enabling families and healthcare providers to make well-informed decisions and alleviating the anxieties and uncertainties associated with pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
- Faculty of Engineering, Tel Aviv University, Tel Aviv 6997801, Israel.
- Edmond J Safra Center for Bioinformatics, Tel Aviv University, Tel Aviv 6997801, Israel.
- Identifai-Genetics Ltd., 24 Raul Wallenberg St., Tel Aviv 6971925, Israel.
- Raphael Recanati Genetic Institute, Rabin Medical Center, Beilinson Hospital, Petah Tikva 4941494, Israel.
- Felsenstein Medical Research Center, Tel-Aviv University, Tel-Aviv, Israel.
ORCID-Profile: Tom Rabinowitz
Zitieren
APA
Schwammenthal, Y., Rabinowitz, T., Basel-Salmon, L., Tomashov-Matar, R., & Shomron, N. (2024). Noninvasive fetal genotyping using deep neural networks. Briefings in Bioinformatics, 26(1). https://doi.org/10.1093/bib/bbaf067
Vancouver
Schwammenthal Y, Rabinowitz T, Basel-Salmon L, Tomashov-Matar R, Shomron N. Noninvasive fetal genotyping using deep neural networks. Briefings in Bioinformatics. 2024;26(1). doi:10.1093/bib/bbaf067
BibTeX
@article{Schwammenthal2024,
author = {Schwammenthal, Yonathan and Rabinowitz, Tom and Basel-Salmon, Lina and Tomashov-Matar, Reut and Shomron, Noam},
title = {Noninvasive fetal genotyping using deep neural networks},
journal = {Briefings in Bioinformatics},
year = {2024},
volume = {26},
number = {1},
doi = {10.1093/bib/bbaf067}
}
EUVIMED